{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:54:44Z","timestamp":1761519284762,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ghir.2019.10.003","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T12:19:02Z","timestamp":1571919542000},"page":"60-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Two years in growth hormone 2017\u201318"],"prefix":"10.1016","volume":"48-49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1225-4537","authenticated-orcid":false,"given":"P.E.","family":"Clayton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Whatmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ghir.2019.10.003_bb0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/archdischild-2014-307228","article-title":"Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence","volume":"101","author":"Murray","year":"2016","journal-title":"Arch. Dis. Child"},{"issue":"2","key":"10.1016\/j.ghir.2019.10.003_bb0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.00012.2004","article-title":"Ghrelin: structure and function","volume":"85","author":"Kojima","year":"2005","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.ghir.2019.10.003_bb0015","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1210\/jc.2018-00665","article-title":"Macimorelin as a diagnostic test for adult GH deficiency","volume":"103","author":"Garcia","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ghir.2019.10.003_bb0020","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93247","article-title":"Transcriptomics and machine learning predict diagnosis and severity of growth hormone deficiency","volume":"3","author":"Murray","year":"2018","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.ghir.2019.10.003_bb0025","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1210\/endo.140.7.6854","article-title":"Growth hormone (gh) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and gh-binding protein","volume":"140","author":"Bresson","year":"1999","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ghir.2019.10.003_bb0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.beem.2015.04.009","article-title":"Hormone replacement therapy in children: the use of growth hormone and IGF-I","volume":"29","author":"Pfaffle","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2019.10.003_bb0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MED.0000000000000416","article-title":"The current state of long-acting growth hormone preparations for growth hormone therapy","volume":"25","author":"Yuen","year":"2018","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"1","key":"10.1016\/j.ghir.2019.10.003_bb0040","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.1038\/s41598-018-28092-8","article-title":"mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH)","volume":"8","author":"Ghasemi","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ghir.2019.10.003_bb0045","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1530\/EJE-16-0111","article-title":"Growth hormone research society perspective on the development of long-acting growth hormone preparations","volume":"174","author":"Christiansen","year":"2016","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2019.10.003_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ghir.2015.07.004","article-title":"Status of long-acting-growth hormone preparations--2015","volume":"25","author":"Hoybye","year":"2015","journal-title":"Growth Hormon. IGF Res."},{"issue":"1","key":"10.1016\/j.ghir.2019.10.003_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrendo.2010.171","article-title":"Growth hormone, the insulin-like growth factor axis, insulin and cancer risk","volume":"7","author":"Clayton","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2019.10.003_bb0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000435856","article-title":"Description of the SAGhE cohort: a large European study of mortality and cancer incidence risks after childhood treatment with recombinant growth Hormone","volume":"84","author":"Swerdlow","year":"2015","journal-title":"Horm. Res. Paediatr."},{"issue":"5","key":"10.1016\/j.ghir.2019.10.003_bb0065","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1210\/jc.2016-2046","article-title":"Cancer risks in patients treated with Growth Hormone in childhood: the SAGhE European cohort study","volume":"102","author":"Swerdlow","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.10.003_bb0070","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/jc.2018-01133","article-title":"Risk of meningioma in European patients treated with Growth Hormone in childhood: results from the SAGhE cohort","volume":"104","author":"Swerdlow","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2019.10.003_bb0075","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jcem.84.4.5634","article-title":"Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS international board. Kabi pharmacia international growth study","volume":"84","author":"Ranke","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"433","key":"10.1016\/j.ghir.2019.10.003_bb0080","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1651-2227.1999.tb14420.x","article-title":"Predicting the response to recombinant human growth hormone in turner syndrome: KIGS models. KIGS international board. Kabi international growth study","volume":"88","author":"Ranke","year":"1999","journal-title":"Acta Paediatr. Suppl."},{"issue":"3","key":"10.1016\/j.ghir.2019.10.003_bb0085","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1210\/jc.2009-1471","article-title":"Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables","volume":"95","author":"Ranke","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.10.003_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12014-017-9160-2","article-title":"The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies","volume":"14","author":"Duran-Ortiz","year":"2017","journal-title":"Clin. Proteomics"},{"issue":"419","key":"10.1016\/j.ghir.2019.10.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan4669","article-title":"A degradation fragment of type X collagen is a real-time marker for bone growth velocity","volume":"9","author":"Coghlan","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.ghir.2019.10.003_bb0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/EJE-13-0069","article-title":"A pharmacogenomic approach to the treatment of children with GH deficiency or turner syndrome","volume":"169","author":"Clayton","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2019.10.003_bb0105","article-title":"Gene expression signatures predict response to therapy with growth hormone","author":"Stevens","year":"2019","journal-title":"J bioRxiv"},{"key":"10.1016\/j.ghir.2019.10.003_bb0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chemosphere.2018.05.102","article-title":"Real-time PCR array to study the effects of chemicals on the growth hormone\/insulin-like growth factors (GH\/IGFs) axis of zebrafish embryos\/larvae","volume":"207","author":"Dang","year":"2018","journal-title":"Chemosphere"},{"issue":"4","key":"10.1016\/j.ghir.2019.10.003_bb0115","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10695-018-0512-2","article-title":"Preparation of biologically active monomeric recombinant zebrafish (Danio rerio) and rainbow trout (Oncorhynchus mykiss) recombinant growth hormones","volume":"44","author":"Oclon","year":"2018","journal-title":"Fish Physiol. Biochem."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637419300528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637419300528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:51:47Z","timestamp":1761087107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637419300528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":23,"alternative-id":["S1096637419300528"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2019.10.003","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two years in growth hormone 2017\u201318","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2019.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}